Carfilzomib Market By Type, By Application By Geographic Scope And Forecast 2034-2034
Carfilzomib Market Overview:
Kyprolis, also known as carfilzomib, is an anti-cancer drug that is made from the naturally occurring substance epoxomicin. Proteasomes are known to be inhibited by oximicin. Carfilzomib inhibits the chymotrypsin-like activity via binding to the 20-S proteasome. It is used as an injection together with other medications like lenalidomide or dexamethasone to...
0 Komentar
0 Bagikan